Tobacco
We are strengthening our tobacco business, our largest business segment, through international expansion, product brand enhancement, and innovation unfettered by convention.
Our core businesses
While on May 7th, 2025, the Company announced entering into an agreement with Shionogi & Co., Ltd. to transfer the pharmaceutical business and our stake in TORII PHARMACEUTICAL CO., LTD.(''Torii''), a consolidated subsidiary of JT, the JT Group's performance and initiatives described on this page include those associated with the pharmaceutical business and Torii.
Please see the press releases on our website for the details.
As announced on September 1, 2025, the transfer of Torii shares has been completed. Please see the press release on our website for the details.
Pharmaceuticals
JT is committed to the research and development of world-class, innovative drugs.
Processed food
Our processed food business meet the needs of our consumers with a variety of safe and delicious meal choices.